期刊
GUT MICROBES
卷 1, 期 5, 页码 293-300出版社
TAYLOR & FRANCIS INC
DOI: 10.4161/gmic.1.5.12924
关键词
probiotic; prebiotic; immunomodulation; immune; human trials; biomarkers; gastrointestinal tract; microbiota
资金
- National Institutes of Diabetes, Digestive and Kidney Disease (NIDDK) [R01 DK56338, P30 DK065075]
- National Center for Complementary and Alternative Medicine (NCCAM) [R01 AT004326]
The study of probiotics and prebiotics is an expanding field of interest and scientific research that has resulted in insights related to the host immune response. Recent advances have naturally led to key questions. What are the specific probiotic components that mediate immunomodulation? Can we extrapolate the results of in vitro studies in animal and human trials? Which biomarkers and immune parameters should be measured in probiotic and prebiotic intervention studies? These questions were part of a discussion entitled How Can Probiotics and Prebiotics Impact Mucosal Immunity at the 2009 Annual Meeting of the International Scientific Association for Probiotics and Prebiotics (ISAPP). This review highlights recent knowledge about the modulation of mucosal immunity by probiotics and prebiotics, as well as considerations for measuring their effects on mucosal immunity. A list of biomarkers and immune parameters to be measured in human clinical trials is included.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据